claim: structural biology helps drive coronavirus vaccine development
evidence_1: the niaid is now working with the biotechnology company moderna, cambridge, ma, to use the latest findings to develop a vaccine candidate using messenger rna (mrna), molecules that serve as templates for making proteins.